<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab2" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <p>Natural antioxidants tested in 
   <italic>in vitro</italic> coronavirus infection models and their main results and mechanism of action.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="1" colspan="1">Antioxidant</th>
    <th align="center" rowspan="1" colspan="1">Type of cells tested</th>
    <th align="center" rowspan="1" colspan="1">Concentration (IC
     <sub>50</sub>)
    </th>
    <th align="center" rowspan="1" colspan="1">Antiviral effect</th>
    <th align="center" rowspan="1" colspan="1">Mechanism of action</th>
    <th align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">(+)-Catechin</td>
    <td align="center" rowspan="1" colspan="1">TGEV-infected ST cells</td>
    <td align="center" rowspan="1" colspan="1">(+)-Catechin (20–80 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of TGEV-induced apoptosis</td>
    <td align="center" rowspan="1" colspan="1">Suppression of the TGEV-induced Bcl-2 reduction, Bax redistribution, cytochrome c release, and caspase-3 activation</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B107" ref-type="bibr">107</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Resveratrol</td>
    <td align="center" rowspan="1" colspan="1">MERS-infected Vero E6 cells.</td>
    <td align="center" rowspan="1" colspan="1">Resveratrol (125-250 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of MERS-induced infection/apoptosis and prolonged cellular survival after virus infection</td>
    <td align="center" rowspan="1" colspan="1">Reduction of the expression of nucleocapsid (N) protein essential for MERS-CoV replication</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B118" ref-type="bibr">118</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Quercetin
     <break/>Epigallocatechin gallate
     <break/>Gallocatechin gallate (GCG)
    </td>
    <td align="center" rowspan="1" colspan="1">Recombinant 3CL
     <sup>pro</sup> was expressed in 
     <italic>Pichia pastoris</italic> GS115
    </td>
    <td align="center" rowspan="1" colspan="1">Quercetin (73 
     <italic>μ</italic>M)
     <break/>Epigallocatechin gallate (73 
     <italic>μ</italic>M)
     <break/>Gallocatechin gallate (47 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of coronavirus replication</td>
    <td align="center" rowspan="1" colspan="1">GCG displayed a binding energy of -14 kcal mol
     <sup>−1</sup> to the active site of 3CL
     <sup>pro</sup> and the galloyl moiety at 3-OH position was required for 3CL
     <sup>pro</sup> inhibition activity
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B114" ref-type="bibr">114</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Quercetin 7-rhamnoside (Q7R)</td>
    <td align="center" rowspan="1" colspan="1">PEDV-infected Vero cells</td>
    <td align="center" rowspan="1" colspan="1">Q7R (10 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Reduction of the formation of a visible cytopathic effect (CPE) without DNA fragmentation</td>
    <td align="center" rowspan="1" colspan="1">Not specificity</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B105" ref-type="bibr">105</xref>, 
     <xref rid="B106" ref-type="bibr">106</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Amentoflavone
     <break/>Apigenin
     <break/>Luteolin
     <break/>Quercetin
     <break/>Quercetin 3-
     <italic>β</italic>-galactoside
     <break/>Herbacetin
     <break/>Rhoifolin
     <break/>Pectolinarin
    </td>
    <td align="center" rowspan="1" colspan="1">SARS-CoV 3CL
     <sup>pro</sup> inhibition using fluorescence resonance energy transfer analysis
     <break/>Molecular docking, SPR/FRET-based bioassays, and mutagenesis
     <break/>Tryptophan-based fluorescence method
    </td>
    <td align="center" rowspan="1" colspan="1">Amentoflavone (8.3 
     <italic>μ</italic>M)
     <break/>Apigenin (208.8 
     <italic>μ</italic>M)
     <break/>Luteolin (20.2 
     <italic>μ</italic>M)
     <break/>Quercetin (23.8 
     <italic>μ</italic>M)
     <break/>Quercetin 3-
     <italic>β</italic>-galactoside (5-200 
     <italic>μ</italic>M)
     <break/>Herbacetin (33.17 
     <italic>μ</italic>M)
     <break/>Rhoifolin (27.45 
     <italic>μ</italic>M)
     <break/>Pectolinarin (37.78 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of SARS-CoV replication</td>
    <td align="center" rowspan="1" colspan="1">Flavonoids exhibited SARS-CoV 3CL
     <sup>pro</sup> inhibitory activity
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B113" ref-type="bibr">113</xref>, 
     <xref rid="B112" ref-type="bibr">112</xref>, 
     <xref rid="B111" ref-type="bibr">111</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Herbacetin, isobavachalcone, quercetin 3-
     <italic>β</italic>-d-glucoside, helichrysetin
    </td>
    <td align="center" rowspan="1" colspan="1">Tryptophan-based fluorescence method</td>
    <td align="center" rowspan="1" colspan="1">Herbacetin (40.59 
     <italic>μ</italic>M)
     <break/>Isobavachalcone (35.85 
     <italic>μ</italic>M)
     <break/>Quercetin 3-
     <italic>β</italic>-d-glucoside (37.03 
     <italic>μ</italic>M)
     <break/>Helichrysetin (67.04 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of MERS-CoV replication</td>
    <td align="center" rowspan="1" colspan="1">Flavonoids exhibited MERS-CoV 3CL
     <sup>pro</sup> inhibitory activity
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B117" ref-type="bibr">117</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Isobavachalcone
     <break/>Psoralidin
    </td>
    <td align="center" rowspan="1" colspan="1">Lineweaver–Burk and Dixon plots</td>
    <td align="center" rowspan="1" colspan="1">Isobavachalcone (7.30 
     <italic>μ</italic>M)
     <break/>Psoralidin (4.02 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of SARS-CoV replication</td>
    <td align="center" rowspan="1" colspan="1">Isobavachalcone and psoralidin exhibited SARS-CoV papain-like protease inhibitory activity</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B115" ref-type="bibr">115</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Myricetin, scutellarein</td>
    <td align="center" rowspan="1" colspan="1">SPR/FRET-based bioassays</td>
    <td align="center" rowspan="1" colspan="1">Myricetin (2.71 
     <italic>μ</italic>M)
     <break/>Scutellarein (0.86 
     <italic>μ</italic>M)
    </td>
    <td align="center" rowspan="1" colspan="1">Inhibition of SARS-CoV replication</td>
    <td align="center" rowspan="1" colspan="1">Myricetin and scutellarein potently inhibit the SARS-CoV helicase protein 
     <italic>in vitro</italic> by affecting the ATPase activity
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B116" ref-type="bibr">116</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
